EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

DHA Alone, EPA + DHA, EPA + DHA + GLA, and EPA + DHA with or Without Vitamin D During Chemotherapy in Women with Breast Cancer: An Intervention- and Outcome-Stratified Systematic Review

Kinga Fronk, Mariusz Wysokiński iD, Rafał Podgórski iD, Edyta Łuszczki iD

Nutrients · 01.08.2026 · 18 (15) · 2483

DOI: 10.3390/nu18152483 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 01.08.2026. Verfasst von Kinga Fronk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, ul. Wilsona 20/5, 33-100 Tarnów, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, Docosahexaenoic Acids, Vitamin D, Eicosapentaenoic Acid. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Prospective studies of omega-3 supplementation during breast cancer chemotherapy differ in intervention composition, co-supplementation, dose, treatment setting, and outcomes. We summarized and critically appraised interventions comprising DHA alone, EPA + DHA, EPA + DHA + GLA, or EPA + DHA with or without vitamin D, stratified by intervention composition and outcome domain.

Methods

PubMed/MEDLINE, the Cochrane Library/CENTRAL, ClinicalTrials.gov, Scopus, Web of Science Core Collection, and Embase were last searched on 8 July 2026, supplemented by citation searching. Eligible studies prospectively administered EPA and/or DHA during chemotherapy and reported inflammatory/biological, nutritional/functional, quality-of-life, treatment-related, anticancer-response, or safety outcomes. Active co-supplementation was analyzed separately. Owing to clinical and methodological heterogeneity, findings were synthesized narratively; risk of bias and outcome-specific certainty were assessed using RoB 2-informed and GRADE approaches.

Results

Fourteen reports representing ten prospective interventional trials were included. No eligible EPA-only trial was found. Interventions comprised EPA + DHA/fish oil without another active nutrient, DHA alone, EPA + DHA plus gamma-linolenic acid, and a factorial trial of EPA + DHA with or without vitamin D. One trial reported lower paclitaxel-induced neuropathy, whereas another found no benefit for paclitaxel-associated acute pain or neuropathic symptoms. Biomarker, nutritional, functional, and quality-of-life findings were inconsistent and often derived from small trials, exploratory or compliance-restricted analyses, companion reports, or co-supplementation designs. No consistent improvement in treatment response or survival was demonstrated. Serious supplementation-related adverse events were not reported, although adverse-event reporting varied. Certainty was low for safety and very low for efficacy-related domains.

Conclusions

Current evidence is preliminary. The evaluated interventions appeared generally tolerated, but independent clinical efficacy of DHA alone, EPA + DHA without another active nutrient, EPA + DHA + GLA, or EPA + DHA with or without vitamin D during breast cancer chemotherapy remains unproven.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDocosahexaenoic AcidsVitamin DEicosapentaenoic AcidDietary SupplementsHumansFemaleTreatment Outcomegamma-Linolenic AcidQuality of Life

Stichwörter der Autor:innen

GRADEbreast cancerchemotherapydocosahexaenoic acideicosapentaenoic acidinflammationnutritional statusomega-3 fatty acidsperipheral neuropathyquality of life

Substanzen

Docosahexaenoic AcidsVitamin DEicosapentaenoic Acidgamma-Linolenic Acid

Autor:innen und Institutionen

  • Independent Researcher, ul. Wilsona 20/5, 33-100 Tarnów, Poland.
  • Department of Fundamentals of Nursing, Chair of Nursing Development, Faculty of Health Sciences, Medical University of Lublin, 20-093 Lublin, Poland.
  • Faculty of Medicine, University of Rzeszów, al. Tadeusza Rejtana 16C, 35-959 Rzeszow, Poland.
  • Faculty of Health Sciences and Psychology, University of Rzeszów, al. Tadeusza Rejtana 16C, 35-959 Rzeszow, Poland.

ORCID-Profile: Mariusz Wysokiński, Rafał Podgórski, Edyta Łuszczki

Zitieren

APA

Fronk, K., Wysokiński, M., Podgórski, R., & Łuszczki, E. (2026). DHA Alone, EPA + DHA, EPA + DHA + GLA, and EPA + DHA with or Without Vitamin D During Chemotherapy in Women with Breast Cancer: An Intervention- and Outcome-Stratified Systematic Review. Nutrients, 18(15), 2483. https://doi.org/10.3390/nu18152483

Vancouver

Fronk K, Wysokiński M, Podgórski R, Łuszczki E. DHA Alone, EPA + DHA, EPA + DHA + GLA, and EPA + DHA with or Without Vitamin D During Chemotherapy in Women with Breast Cancer: An Intervention- and Outcome-Stratified Systematic Review. Nutrients. 2026;18(15):2483. doi:10.3390/nu18152483

BibTeX
@article{Fronk2026,
  author = {Fronk, Kinga and Wysokiński, Mariusz and Podgórski, Rafał and Łuszczki, Edyta},
  title = {DHA Alone, EPA + DHA, EPA + DHA + GLA, and EPA + DHA with or Without Vitamin D During Chemotherapy in Women with Breast Cancer: An Intervention- and Outcome-Stratified Systematic Review},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2483},
  doi = {10.3390/nu18152483}
}
Kostenlos starten →